Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-21

Clinical Trial Update: Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against Metoprolol [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing nebivolol to metoprolol in adults with hypertension has completed, evaluating effects on subclinical left ventricular dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METOPROLOL (METOPROLOL TARTRATE)
  • Nebivolol (Nebivolol)

Snippet

Sponsor: Berlin-Chemie Menarini | Conditions: Primary Arterial Hypertension | Phase 3 | Status: COMPLETED